Evidence map›Paper›PMID 39906762›Full record

ArticleAnnals of biomedical research2024

Grk1 Missense Mutations in Type II Oguchi Disease: A Literature Review.

Theodore Edward Margo, Frank Sungping Chen, Yu-Jiun Chen, Ching-Kang Chen

Abstract read
In one paragraph

Article in Annals of biomedical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Theodore Edward MargoDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Frank Sungping ChenDivision of Otolaryngology, PeaceHealth Medical Group, Eugene, Oregan, OR 97401, USA.
Yu-Jiun ChenDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Ching-Kang ChenDepartment of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

Funding

RECOVERY OF PHOTOTRANSDUCTIONR01EY013811 · NEI · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHEN, CHING-KANG JASON · 2002 to 2017
$5.2M
The function of wide-field amacrine cells in mammalian retinaR01EY034219 · NEI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Ching-Kang Jason Chen · 2022 to 2026
$1.9M
Transducin and melanopsin independent phototransduction in postnatal retinal developmentR01EY032898 · NEI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Ching-Kang Jason Chen · 2022 to 2026
$1.7M
Recovery of PhototransductionR56EY013811 · NEI · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHEN, CHING-KANG JASON · 2007 to 2007
$373k
NEI NIH HHS R01 EY013811NEI NIH HHS R01 EY032898NEI NIH HHS R01 EY034219NEI NIH HHS R56 EY013811
6 · The paper itself

Abstract

Oguchi disease is a rare form of congenital stationary night blindness resulting from arrestin-1 (SAG) or rhodopsin kinase (GRK1) loss-of-function mutations. Unlike other congenital nyctalopias, patients with Oguchi disease can reach the dark-adapted state, albeit only after several hours of sustained darkness exposure. The mechanism underlying rhodopsin kinase dysfunction in Oguchi disease remains understudied. Previous research utilized the Grk1 knockout mice to reveal its role in phototransduction, the process that transduces light into neuronal signals in rod and cone photoreceptors. By studying Grk1 missense mutations via a knock-in approach, a more complete picture of the Oguchi disease mechanism involving GRK1 may be readily harvested. We summarize here the current knowledge on the Type II Oguchi disease with Grk1 missense mutations by focusing on the interaction of GRK1 with other proteins, and how these interactions influence dark adaptation. We call for more detailed analyses of GRK1 missense mutations in animal models, particularly V380D and L157P, to reveal novel disease mechanisms to gain further insight onto GRK1's action and function.

Indexed as

Congenital Stationary Night Blindness (CSNB)Electroretinography (ERG)GRK1GRK7Mizuo-Nakamura phenomenonOguchi diseasePhototransductionRetinitis Pigmentosa (RP)Rhodopsin phosphorylation

Identifiers

PMID39906762
PMCPMC11793915

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.